Neoadjuvant Treatment for Rectal Cancer
Author Information
Author(s): Ferrigno Robson, Novaes Paulo Eduardo Ribeiro dos Santos, Silva Maria Letícia Gobo, Nishimoto Ines Nobuko, Nakagawa Wilson Toshihiko, Rossi Benedito Mauro, Ferreira Fábio de Oliveira, Lopes Ademar
Primary Institution: Hospital do Câncer A. C. Camargo
Hypothesis
The study aims to analyze the effectiveness of neoadjuvant radiochemotherapy in patients with locally advanced rectal cancer.
Conclusion
The neoadjuvant treatment was effective for local control, but fixation of the tumor and lymph node metastasis were significant adverse prognostic factors.
Supporting Evidence
- Complete response was observed in 7.9% of patients.
- Overall survival at five years was 52.6%.
- Distant metastasis occurred in 39.6% of patients.
- Patients with fixed tumors had significantly lower overall survival.
- Postoperative TNM stage was a significant factor for disease-free survival.
Takeaway
Doctors used a special treatment before surgery to help patients with rectal cancer, and it worked well for keeping the cancer from coming back.
Methodology
Patients received preoperative radiotherapy and chemotherapy, followed by surgery, with various prognostic factors analyzed for survival outcomes.
Potential Biases
Potential biases due to the retrospective nature of the study and selection of patients.
Limitations
The study is retrospective and may not account for all variables affecting outcomes.
Participant Demographics
Median age was 62 years, with 51.5% male and 48.5% female participants.
Statistical Information
P-Value
p < 0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website